Cidara Therapeutics, Inc.·4

Apr 4, 5:07 PM ET

Tari Leslie 4

4 · Cidara Therapeutics, Inc. · Filed Apr 4, 2022

Insider Transaction Report

Form 4
Period: 2022-03-31
Tari Leslie
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Common Stock

    2022-03-31+52,500207,900 total
  • Award

    Employee Stock Option (right to buy)

    2022-03-31+105,000105,000 total
    Exercise: $0.83Exp: 2032-03-30Common Stock (105,000 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    13,298
Footnotes (2)
  • [F1]Represents time-based Restricted Stock Units (RSUs) granted on March 31, 2022. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2023, 2024, and 2025, subject to continuous service through each such vesting date.
  • [F2]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2022.

Documents

1 file
  • 4
    wf-form4_164910642754814.xmlPrimary

    FORM 4